Maxposure Ltd

As of 01-October, Maxposure Ltd's stock price is rising to 57.90, up 9.76%, and has outperformed its sector today. Despite recent gains, the stock has a year-to-date decline of 34.17%, contrasting with the Sensex's 5.04% increase.

As of 30-Sep, Maxposure Ltd's stock price is declining at 52.75, down 3.03%, with significant underperformance indicated by negative returns over the past week and month. The stock is trading below all major moving averages, reflecting weak investor sentiment and a lack of confidence.

As of 24-Sep, Maxposure Ltd is priced at 57.00, with a year-to-date decline of 35.19% and a 52.68% drop over the past year, indicating significant underperformance compared to the broader market and its sector. Despite today's performance showing a slight outperformance against its sector, the stock remains in a bearish trend, trading below all key moving averages.

As of 23-Sep, Maxposure Ltd's stock price is declining at 57.00, down 0.96%, and has underperformed its sector by 4.12%. The stock is trading below all major moving averages and has seen a significant drop in investor participation, with a year-to-date decline of 35.19%.

As of 22-Sep, Maxposure Ltd's stock price is declining at 57.55, down 2.04%, and has underperformed its sector by 2.76%. The stock has seen a significant drop in investor participation and has decreased 34.57% year-to-date, indicating ongoing challenges for the company.

As of 19-Sep, Maxposure Ltd's stock price is at 58.75, up 1.29% today, but down 33.20% year-to-date. While it has outperformed its sector recently, its long-term performance remains weak compared to the broader market.

As of 18-Sep, Maxposure Ltd's stock price is at 58.00, showing a slight increase today but a significant decline of 34.05% year-to-date. The stock has underperformed relative to the market, with decreased investor participation indicating potential lack of confidence.

As of 17-Sep, Maxposure Ltd's stock price is declining at 57.60, down 0.6%, and is trading below all key moving averages, indicating a bearish trend. The stock has significantly underperformed year-to-date with a 34.51% decline, contrasting with the broader market's positive performance.

As of 16-Sep, Maxposure Ltd's stock price is 57.95, down 0.09%, and has underperformed its sector by 1.65%. The stock is trading below all moving averages, with a year-to-date decline of 34.11%, indicating ongoing challenges amid a generally positive market.

As of 15-Sep, Maxposure Ltd's stock price is at 58.00, up 1.05%, but it has underperformed its sector and the broader market significantly, with a year-to-date decline of 34.05%. Investor participation has also dropped sharply, indicating weak sentiment towards the stock.

As of 12-Sep, Maxposure Ltd's stock price is at 57.40, down 0.26%, with a 34.74% decline year-to-date and significantly underperforming compared to the broader market. The stock is trading below all key moving averages and has seen a drastic drop in investor participation, indicating reduced interest.

As of 11-Sep, Maxposure Ltd's stock price is 57.55, down 1.12%, and trading below all key moving averages, indicating a bearish trend. The stock has underperformed significantly over the past month and year, with declines of 0.78% and 42.68%, respectively, while the Sensex has shown stronger performance.

As of 10-Sep, Maxposure Ltd's stock price is at 58.20, down 0.26%, and is trading below all key moving averages, indicating a bearish trend. Despite a slight weekly gain, the stock has significantly underperformed over the past month and year, with declines of 1.44% and 45.04%, respectively, compared to a relatively stable Sensex.

As of September 9, 2025, Maxposure is considered a very attractive investment due to its undervalued status, strong financial ratios like a PE of 15.88 and ROCE of 26.06%, and favorable comparison to peers, despite a year-to-date stock decline of -33.66%.

As of 09-Sep, Maxposure Ltd's stock price is at 58.35, down 5.58% today and significantly underperforming its sector. Despite a recent increase in investor participation, the stock has seen substantial declines over the past year and year-to-date, indicating a lack of confidence among investors compared to the broader market.

As of September 8, 2025, Maxposure's valuation has shifted to fair, with a PE Ratio of 16.77, an EV to EBITDA of 11.32, and a ROCE of 26.06%, indicating it is fairly valued compared to peers like Prime Focus, but it has underperformed the Sensex by 43.09% over the past year.

As of 08-Sep, Maxposure Ltd's stock price is at 61.80, up 4.22% recently, with a significant short-term rise of 7.95% over the past week. However, it remains down 29.73% year-to-date and underperformed its sector today, indicating ongoing challenges despite recent gains.

As of 05-September, Maxposure Ltd's stock price is at 59.30, up 3.31% with increased investor participation, but it has underperformed its sector and the Sensex year-to-date. Despite short-term gains, the stock's long-term performance remains concerning due to significant past declines.

As of 04-Sep, Maxposure Ltd's stock price is at 57.40, down 0.15 or 0.26%, and has significantly underperformed its sector and the broader market, with a year-to-date decline of 34.74%. The stock is trading below all major moving averages, indicating a bearish trend and weak investor sentiment.